Scarica l'app Stockscreener
6.88
0.72%
-0.05
Dopo l'orario di chiusura:
6.88
Precedente Chiudi:
$6.93
Aprire:
$6.92
Volume 24 ore:
194.29K
Relative Volume:
0.50
Capitalizzazione di mercato:
$460.22M
Reddito:
$555.06M
Utile/perdita netta:
$-39.48M
Rapporto P/E:
-11.47
EPS:
-0.6
Flusso di cassa netto:
$29.05M
1 W Prestazione:
+4.40%
1M Prestazione:
+0.58%
6M Prestazione:
-11.57%
1 anno Prestazione:
-46.75%
Intervallo 1D:
$6.82
$7.05
Intervallo di 1 settimana:
$6.37
$7.05
Portata 52W:
$5.81
$14.38
Bioventus Inc Stock (BVS) Company Profile
Nome
Bioventus Inc
Settore
Industria
Telefono
(919) 474-6700
Indirizzo
4721 EMPEROR BOULEVARD, SUITE 100, DURHAM
Confronta BVS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BVS
Bioventus Inc
|
6.88 | 446.84M | 555.06M | -39.48M | 29.05M | -0.60 |
|
ABT
Abbott Laboratories
|
127.63 | 231.95B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
97.78 | 142.60B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
369.25 | 141.45B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.04 | 123.83B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
72.65 | 43.07B | 5.69B | 1.41B | 577.90M | 6.9828 |
Bioventus Inc Stock (BVS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-07 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-12-17 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2023-12-07 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2023-08-09 | Aggiornamento | Craig Hallum | Hold → Buy |
| 2022-11-22 | Downgrade | Craig Hallum | Buy → Hold |
| 2022-11-09 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2022-11-09 | Downgrade | JP Morgan | Overweight → Underweight |
| 2022-03-15 | Iniziato | Craig Hallum | Buy |
| 2021-11-15 | Ripresa | Morgan Stanley | Overweight |
| 2021-11-10 | Ripresa | JP Morgan | Overweight |
| 2021-07-01 | Downgrade | Goldman | Buy → Neutral |
| 2021-03-08 | Iniziato | Canaccord Genuity | Buy |
| 2021-03-08 | Iniziato | Goldman | Buy |
| 2021-03-08 | Iniziato | JP Morgan | Overweight |
| 2021-03-08 | Iniziato | Morgan Stanley | Overweight |
Mostra tutto
Bioventus Inc Borsa (BVS) Ultime notizie
Should you wait for a breakout in Bioventus Inc.2025 Price Momentum & Advanced Technical Signal Analysis - newser.com
Bioventus Inc. stock chart pattern explained2025 Breakouts & Breakdowns & Safe Investment Capital Preservation Plans - newser.com
Forecasting Bioventus Inc. price range with options dataPortfolio Gains Report & Step-by-Step Trade Execution Guides - newser.com
Head-To-Head Comparison: Vyome (NASDAQ:HIND) vs. Bioventus (NASDAQ:BVS) - Defense World
Head-To-Head Survey: Bioventus (NASDAQ:BVS) & Shoulder Innovations (NYSE:SI) - Defense World
Analyzing TranS1 (OTCMKTS:BAXSQ) and Bioventus (NASDAQ:BVS) - Defense World
Analyzing recovery setups for Bioventus Inc. investorsM&A Rumor & Weekly High Conviction Ideas - newser.com
Bioventus Inc. stock retracement – recovery analysisWeekly Investment Recap & Fast Entry Momentum Trade Alerts - newser.com
Bioventus (NASDAQ:BVS) Earns "Sell (D-)" Rating from Weiss Ratings - MarketBeat
What technical models suggest about Bioventus Inc.’s comebackJuly 2025 Update & Expert Curated Trade Ideas - newser.com
Full technical analysis of Bioventus Inc. stockMarket Performance Recap & Real-Time Volume Trigger Notifications - newser.com
Is Bioventus Inc a good long term investmentSwing Trading Ideas & Rapid Capital Gain - earlytimes.in
290,700 Shares in Bioventus Inc. $BVS Acquired by Knights of Columbus Asset Advisors LLC - MarketBeat
Multi factor analysis applied to Bioventus Inc.Earnings Summary Report & Breakout Confirmation Trade Signals - newser.com
Volatility clustering patterns for Bioventus Inc.Quarterly Portfolio Summary & Daily Oversold Stock Bounce Ideas - newser.com
Can Bioventus Inc. hit a new high this monthPortfolio Value Report & Technical Pattern Alert System - newser.com
How Bioventus Inc. stock benefits from strong dollarPortfolio Update Summary & Reliable Intraday Trade Plans - newser.com
Using Bollinger Bands to evaluate Bioventus Inc.Trade Analysis Summary & Free Fast Gain Swing Trade Alerts - newser.com
Bioventus Inc Stock Analysis and ForecastBear Market Strategies & In-Depth Analyst Ratings Explained Simply - earlytimes.in
What drives Bioventus Inc stock priceBreakout Stock Watch & Small Investment Portfolio Growth - earlytimes.in
PetVivo (NASDAQ:PETV) versus Bioventus (NYSE:BVS) Head-To-Head Comparison - Defense World
Comparing Bioventus Inc. in custom built stock radarsProduct Launch & Fast Entry Momentum Alerts - newser.com
Comparing Bioventus (NYSE:BVS) and Retractable Technologies (NYSE:RVP) - Defense World
Orthobiologics Market May See a Big Move | Major Giants Medtronic, Zimmer Biomet, Bioventus - newstrail.com
Is Bioventus Inc. building a consolidation baseTreasury Yields & Weekly Chart Analysis and Trade Guides - newser.com
Bioventus (NYSE:BVS) Shares Gap DownHere's What Happened - MarketBeat
Bioventus Inc. stock daily chart insightsBull Run & Technical Pattern Recognition Alerts - newser.com
Craig-Hallum Maintains Bioventus(BVS.US) With Buy Rating - 富途牛牛
Bioventus Inc Azioni (BVS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Bioventus Inc Azioni (BVS) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Bartholdson John A. | Director |
Jun 02 '25 |
Option Exercise |
0.00 |
26,493 |
0 |
72,045 |
| SUTTER MARTIN P | Director |
Jun 02 '25 |
Option Exercise |
0.00 |
26,493 |
0 |
85,241 |
| STALNECKER SUSAN M | Director |
Jun 02 '25 |
Option Exercise |
0.00 |
26,493 |
0 |
105,957 |
| NOHRA GUY P | Director |
Jun 02 '25 |
Option Exercise |
0.00 |
26,493 |
0 |
126,610 |
| NEELS GUIDO J | Director |
Jun 02 '25 |
Option Exercise |
0.00 |
26,493 |
0 |
85,241 |
| McMurry-Heath Michelle | Director |
Jun 02 '25 |
Option Exercise |
0.00 |
26,493 |
0 |
74,698 |
| Ladone Mary Kay | Director |
Jun 02 '25 |
Option Exercise |
0.00 |
26,493 |
0 |
78,981 |
| HAWKINS WILLIAM A | Director |
Jun 02 '25 |
Option Exercise |
0.00 |
26,493 |
0 |
257,851 |
| Beyer Pat | Director |
Jun 02 '25 |
Option Exercise |
0.00 |
26,493 |
0 |
76,436 |
| Singleton Mark Leonard | SVP & CFO |
Apr 11 '25 |
Sale |
7.57 |
3,875 |
29,334 |
141,088 |
1.23%
0.38%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):